NEW YORK, May 5 (GenomeWeb News) - Bruker BioSciences yesterday reported increased revenues and earnings for the first quarter of 2004.


Revenues for the quarter were $68.2 million, up from $63.1 million during the first quarter of 2003. Almost three quarters of these revenues resulted from life science mass spectrometry systems.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.